Nextech Invest Ag Tango Therapeutics, Inc. Transaction History
Nextech Invest Ag
- $530 Million
- Q2 2024
A detailed history of Nextech Invest Ag transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Nextech Invest Ag holds 5,533,980 shares of TNGX stock, worth $30.1 Million. This represents 8.96% of its overall portfolio holdings.
Number of Shares
5,533,980
Previous 5,533,980
-0.0%
Holding current value
$30.1 Million
Previous $43.9 Million
8.06%
% of portfolio
8.96%
Previous 8.22%
Shares
1 transactions
Others Institutions Holding TNGX
# of Institutions
119Shares Held
89MCall Options Held
2.6KPut Options Held
1K-
Trv Gp Iv, LLC Boston, MA19.2MShares$104 Million81.48% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA13.3MShares$72.5 Million4.04% of portfolio
-
Boxer Capital, LLC San Diego, CA8.2MShares$44.6 Million3.91% of portfolio
-
Southpoint Capital Advisors LP New York, NY5.28MShares$28.7 Million1.32% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.76MShares$25.9 Million0.03% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $479M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...